Diabetes Mellitus, Experimental
"Diabetes Mellitus, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY.
Descriptor ID |
D003921
|
MeSH Number(s) |
C18.452.394.750.074 C19.246.240 E05.598.500.374
|
Concept/Terms |
Streptozotocin Diabetes- Streptozotocin Diabetes
- Diabetes, Streptozotocin
- Streptozocin Diabetes
- Diabete, Streptozocin
- Diabetes, Streptozocin
- Streptozocin Diabete
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Experimental".
This graph shows the total number of publications written about "Diabetes Mellitus, Experimental" by people in this website by year, and whether "Diabetes Mellitus, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 0 | 2 |
1995 | 1 | 0 | 1 |
1996 | 2 | 1 | 3 |
1997 | 2 | 0 | 2 |
2001 | 0 | 1 | 1 |
2002 | 1 | 0 | 1 |
2003 | 2 | 1 | 3 |
2004 | 3 | 1 | 4 |
2005 | 2 | 3 | 5 |
2006 | 1 | 1 | 2 |
2007 | 2 | 2 | 4 |
2008 | 3 | 0 | 3 |
2009 | 1 | 0 | 1 |
2010 | 2 | 1 | 3 |
2011 | 1 | 0 | 1 |
2012 | 4 | 0 | 4 |
2013 | 6 | 1 | 7 |
2014 | 5 | 1 | 6 |
2015 | 4 | 1 | 5 |
2016 | 5 | 2 | 7 |
2017 | 4 | 2 | 6 |
2018 | 4 | 2 | 6 |
2019 | 6 | 0 | 6 |
2020 | 4 | 1 | 5 |
2021 | 5 | 2 | 7 |
2022 | 5 | 1 | 6 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Mellitus, Experimental" by people in Profiles.
-
Acute Ischemic Stroke by Middle Cerebral Artery Occlusion in Rat Models of Diabetes: Importance of Pre-op and Post-op Care, Severity of Hyperglycemia, and Sex. Methods Mol Biol. 2023; 2616:467-479.
-
Deferoxamine prevents poststroke memory impairment in female diabetic rats: potential links to hemorrhagic transformation and ferroptosis. Am J Physiol Heart Circ Physiol. 2023 02 01; 324(2):H212-H225.
-
Cerebral microvascular matrix metalloproteinase-3 (MMP3) contributes to vascular injury after stroke in female diabetic rats. Neurochem Int. 2023 01; 162:105462.
-
Magnetic resonance imaging reveals microemboli-mediated pathological changes in brain microstructure in diabetic rats: relevance to vascular cognitive impairment/dementia. Clin Sci (Lond). 2022 11 11; 136(21):1555-1570.
-
Contralesional angiotensin type 2 receptor activation contributes to recovery in experimental stroke. Neurochem Int. 2022 09; 158:105375.
-
Activation of T cell checkpoint pathways during ?-cell antigen presentation by engineered dendritic cells promotes protection from type 1 diabetes. Immunology. 2022 07; 166(3):341-356.
-
Impact of diabetes and ischemic stroke on the cerebrovasculature: A female perspective. Neurobiol Dis. 2022 06 01; 167:105667.
-
Comparisons of a2-Adrenergic Agents, Medetomidine and Xylazine, with Pentobarbital for Anesthesia: Important Pitfalls in Diabetic and Nondiabetic Rats. J Ocul Pharmacol Ther. 2022 03; 38(2):156-166.
-
Gastrin producing syngeneic mesenchymal stem cells protect non-obese diabetic mice from type 1 diabetes. Autoimmunity. 2022 03; 55(2):95-108.
-
Tofacitinib Ameliorates Retinal Vascular Leakage in a Murine Model of Diabetic Retinopathy with Type 2 Diabetes. Int J Mol Sci. 2021 Nov 02; 22(21).